This collection of information is
required by 35 U.S.C 156 and Administered through 37 CFR 1.710
through 1.791. The USPTO, together with the Sec. of Health &
Human Servies and the Dept. of Agriculture, administers 35 U.S.C.
156 (Federal Food Drug, and Cosmetic Act), which permits the USPTO
to restore the patent term lost due to certain types of regulatory
review by the Federal Food and Drug Administration or the Dept. of
Agriculture. The USPTO and the public use the information to extend
the patient term past its original expiration date; to petition for
review of informal extensions of applications, final eligibility
.........
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.